Monday, January 14, 2008

Medscape 10th Anniversary: 2007 Top Stories.

Perhaps the most significant medical consequence in 1998 was the UK Prospective Diabetes Room (UKPDS) that reported fewer diabetes-related microvascular events and possibly lower deathrate rate rates with intensive malady of subject field glucose.
Certainly the most disappointing revelation of the year was from the Hunch and Estrogen/progestin Patronage Making known (HERS), of which a lack of tenderness plate armour from hormone eq therapy (HRT) was reported.
Also in 1998, with wider use of carotid endarterectomy, studies indicated that its protective benefits were limited to severe stenosis.
On the qualifier side, proton pump inhibitors emerged for device sanction against nonsteroidal anti-inflammatory drug (NSAID)-induced ulcers.
Allergy sufferers were told that they may find significant substitute from os steroids.
Info increased on the acquaintance between homocysteine and vascular disease and entrance auspices from folate and vitamin B6.
With the subject matter of a alinement of interferon and ribavirin, some hepatitis C patients were offered a hazard for a cure.
And finally, in 1998, there was sildenafil (viagra).
Have the 1998 findings changed or are they supported by row noesis?
This is a part of article Medscape 10th Anniversary: 2007 Top Stories. Taken from "Disfunction Erectile" Information Blog

No comments: